Select Page
ONEpossible 2022

ONEpossible 2022

In 2020, PRF checked off an important mission milestone: U.S. Food and Drug Administration (FDA) approval of lonafarnib (brand name Zokinvy®), the first-ever treatment for Progeria. Since then, and through tremendous effort and expense, PRF and partner Eiger...
PRF’s 10th International Scientific Workshop

PRF’s 10th International Scientific Workshop

Over 370 registrants from 30 countries attended our 1st ever web-based Scientific Meeting! We hope you enjoy this clip from our 2020 International Workshop, “Researching Possibilities, ExTENding Lives” webinar  All rights reserved. Please do not download, copy,...